Exam 2-M4-6 Flashcards
Nicotine replacement: indications, contra’s, and adverse effects
Ind: Gum: smokers 25+/day 4mg/hr; lozenge: if smoke within 30 min of waking; patch: cannot smoke while on patch; E-cigs not recommended;
Contra: pregnancy (C), post MI/CVA
AE: behavioral changes, agitation, depression, SI; patch-toxicity
- Clonidine has several off-label uses, including:
a. Alcohol and nicotine withdrawal
b. Post-herpetic neuralgia
c. Both 1 and 2
d. Neither 1 nor 2,
3 Both 1 and 2
Alpha2 adrengeripc agonist
- Nicotine has a variety of effects on nicotinic receptors throughout the body. Which of the
following is NOT an effect of nicotine? - Vasodilation and decreased heart rate
- Increased secretion of gastric acid and motility of the GI smooth muscle
- Release of dopamine at the pleasure center
- Stimulation of the locus coeruleus
- Vasodilation and decreased heart rate
- Nicotine gum products are:
- Chewed to release the nicotine and then swallowed for a systemic effect
- “Parked” in the buccal area of the mouth to produce a constant amount of nicotine
release - Bound to exchange resins so the nicotine is only released during chewing
- Approximately the same in nicotine content as smoking two cigarettes
- Bound to exchange resins so the nicotine is only released during chewing
Nicotine replacement therapy (NRT):
1. Is widely distributed in the body only when the gum products are used
2. Does not cross the placenta and so is safe for pregnant women
3. Delays healing of esophagitis and peptic ulcers
4. Has no drug interactions when a transdermal patch is used
- Delays healing of esophagitis and peptic ulcers
Varenicline (Chantix) may be prescribed for tobacco cessation. Instructions to the patient who is starting varenicline include:
1. The maximum time varenicline can be used is 12 weeks.
2. Nausea is a sign of varenicline toxicity and should be reported to the provider.
3. The starting regimen for varenicline is start taking 1 mg twice a day a week before the quit date.
4. Neuropsychiatric symptoms may occur.
- Neuropsychiatric symptoms may occur.
If prescribing bupropion (Zyban) for tobacco cessation, the instructions to the patient include:
1. Bupropion (Zyban) is started 1 to 2 weeks before the quit date.
2. Nicotine replacement products should not be used with bupropion.
3. If they smoke when taking bupropion they may have increased anxiety and insomnia.
4. Because they are not using bupropion as an antidepressant, they do not need to worry about increased suicide ideation when starting therapy.
- Bupropion (Zyban) is started 1 to 2 weeks before the quit date.
When a patient is prescribed nicotine nasal spray for tobacco cessation, instructions include:
1. Inhale deeply with each dose to ensure deposition in the lungs.
2. The dose is one to two sprays in each nostril per hour, not to exceed 40 sprays per day.
3. If they have a sensation of “head rush” this indicates the medication is working
well.
4. Nicotine spray may be used for up to 12 continuous months.
- The dose is one to two sprays in each nostril per hour, not to exceed 40 sprays per day.
Transdermal nicotine replacement (the patch) is an effective choice in tobacco cessation because:
1.The patch provides a steady level of nicotine without reinforcing oral aspects of smoking.
2.There is the ability to “fine tune” the amount of nicotine that is delivered to the
patient at any one time.
3. There is less of a problem with nicotine toxicity than with other forms of nicotine replacement.
4. Transdermal nicotine is safer in pregnancy.
1.The patch provides a steady level of nicotine without reinforcing oral aspects of smoking.
Instructions for the use of nicotine gum include:
1.Chew the gum quickly to get a peak effect.
2.The gum should be “parked” in the buccal space between chewing.
3.Acidic drinks such as coffee help with the absorption of the nicotine.
4.The highest abstinence rates occur if the patient chews the gum when he or she is having cravings.
2.The gum should be “parked” in the buccal space between chewing.
Nicotine replacement therapy should not be used in which patients?
1.Pregnant women
2.Patients with worsening angina pectoris
3.Patients who have just suffered an acute myocardial infarction
4.All of the above
4.All of the above
The most appropriate smoking cessation prescription for pregnant women is:
1. A nicotine replacement patch at the lowest dose available
2. Bupropion (Zyban)
3. Varenicline (Chantix)
4. Nonpharmacologic measures
- Nonpharmacologic measures
Drug resistant tuberculosis (TB) is defined as TB that is resistant to:
1.Fluoroquinolones
2.Rifampin and isoniazid
3.Amoxicillin
4.Ceftriaxone
2.Rifampin and isoniazid
Goals when treating tuberculosis include:
1.Completion of recommended therapy
2.Negative purified protein derivative at the end of therapy
3.Completely normal chest x-ray
4.All of the above
1.Completion of recommended therapy
The principles of drug therapy for the treatment of tuberculosis include:
1.Patients are treated with a drug to which M. tuberculosis is sensitive.
2.Drugs need to be taken on a regular basis for a sufficient amount of time.
3.Treatment continues until the patient’s purified protein derivative is negative.
4.All of the above
2.Drugs need to be taken on a regular basis for a sufficient amount of time.
Kaleb has extensively resistant tuberculosis (TB). Treatment for extensively resistant TB wouldinclude:
1.INH, rifampin, pyrazinamide, and ethambutol for at least 12 months
2.INH, ethambutol, kanamycin, and rifampin
3.Treatment with at least two drugs to which the TB is susceptible
4.Levofloxacin
3.Treatment with at least two drugs to which the TB is susceptible
Isabella has confirmed tuberculosis and is placed on a 6-month treatment regimen. The 6-month regimen consists of:
1.Two months of four-drug therapy (INH, rifampin, pyrazinamide, and ethambutol) followed by Four months of INH and rifampin
2.Six months of INH with daily pyridoxine throughout therapy
3.Six months of INH, rifampin, pyrazinamide, and ethambutol
4.Any of the above
1.Two months of four-drug therapy (INH, rifampin, pyrazinamide, and ethambutol) followed by Four months of INH and rifampin
Lila is 24 weeks pregnant and has been diagnosed with tuberculosis (TB). Treatment regimens for a pregnant patient with TB would include:
1.Streptomycin
2.Levofloxacin
3.Kanamycin
4.Pyridoxine
4.Pyridoxine
Bilal is a 5-year-old patient who has been diagnosed with tuberculosis. His treatment would include:
1.Pyridoxine
2.Ethambutol
3.Levofloxacin
4. Rifabutin
1.Pyridoxine
Ezekiel is a 9-year-old patient who lives in a household with a family member newly diagnosed with tuberculosis (TB). To prevent Ezekiel from developing TB he should be treated with:
1. 6 months of Isoniazid (INH) and rifampin
2. 2 months of INH, rifampin, pyrazinamide, and ethambutol, followed by 4 months of INH
3. 9 months of INH
4. 12 months of INH
- 9 months of INH
Leonard is completing a 6-month regimen to treat tuberculosis (TB). Monitoring of a patient on TB therapy includes:
1. Monthly sputum cultures
2. Monthly chest x-ray
3. Bronchoscopy every 3 months
4. All of the above
- Monthly sputum cultures
Caleb is an adult with an upper respiratory infection (URI). Treatment for his URI would include:
1.Amoxicillin
2.Diphenhydramine
3.Phenylpropanolamine
4.Topical oxymetazoline
4.Topical oxymetazoline
Rose is a 3-year-old patient with an upper respiratory infection (URI). Treatment for her URI would include:
1.Amoxicillin
2.Diphenhydramine
3.Pseudoephedrine
4.Nasal saline spray
4.Nasal saline spray
Patients who should be cautious about using decongestants for an upper respiratory infection (URI)include:
1.School-age children
2.Patients with asthma
3.Patients with cardiac disease
4.Patients with allergies
3.Patients with cardiac disease
Jaheem is a 10-year-old low-risk patient with sinusitis. Treatment for a child with sinusitis is:
1.Amoxicillin
2.Azithromycin
3.Cephalexin
4.Levofloxacin
1.Amoxicillin
Jacob has been diagnosed with sinusitis. He is the parent of a child in daycare. Treatment for sinusitis in an adult who has a child in daycare is:
1.Azithromycin 500 mg q day for 5 days
2.Amoxicillin-clavulanate 500 mg bid for 7 days
3.Ciprofloxacin 500 mg bid for 5 days
4.Cephalexin 500 mg qid for 5 days
2.Amoxicillin-clavulanate 500 mg bid for 7 days
The length of treatment for sinusitis in a low-risk patient should be:
1.5–7 days
2.7–10 days
3.14–21 days
4.7 days beyond when symptoms cease
1.5–7 days
Patient education for a patient who is prescribed antibiotics for sinusitis includes:
1.Use of nasal saline washes
2.Use of inhaled corticosteroids
3.Avoiding the use of ibuprofen while ill
4.Use of laxatives to treat constipation
1.Use of nasal saline washes
Myles is a 2-year-old patient who has been diagnosed with acute otitis media. He is afebrile and has not been treated with antibiotics recently. First-line treatment for his otitis media would include:
1. Azithromycin
2. Amoxicillin
3. Ceftriaxone
4. Trimethoprim/sulfamethoxazole
- Amoxicillin
Alyssa is a 15-month-old patient who has been on amoxicillin for 2 days for acute otitis media. She is still febrile and there is no change in her tympanic membrane examination. What would be the plan of care for her?
1. Continue the amoxicillin for the full 10 days.
2. Change the antibiotic to azithromycin.
3. Change the antibiotic to amoxicillin/clavulanate.
4. Change the antibiotic to trimethoprim/sulfamethoxazole.
- Change the antibiotic to amoxicillin/clavulanate.
A child that may warrant “watchful waiting” instead of prescribing an antibiotic for acute otitis media includes patients who:
1. Are low risk with temperature of less than 39 or 102.2
2. Have reliable parents with transportation
3. Are older than age 2 years
4. All of the above
- All of the above
Whether prescribing an antibiotic for a child with acute otitis media or not, the parents should be educated about:
1. Using decongestants to provide faster symptom relief
2. Providing adequate pain relief for at least the first 24 hours
3. Using complementary treatments for acute otitis media, such as garlic oil
4. Administering an antihistamine/decongestant combination (Dimetapp) so the child can sleep better
- Providing adequate pain relief for at least the first 24 hours
First-line therapy for a patient with acute otitis externa (swimmer’s ear) and an intact tympanic membrane includes:
1. Swim-Ear drops
2. Ciprofloxacin and hydrocortisone drops
3. Amoxicillin
4. Gentamicin ophthalmic drops
- Ciprofloxacin and hydrocortisone drops
Long-acting beta-agonists (LTBAs) received a Black Box Warning from the U.S. Food and Drug Administration due to the:
1.Risk of life-threatening dermatological reactions
2.Increased incidence of cardiac events when LTBAs are used
3.Increased risk of asthma-related deaths when LTBAs are used
4.Risk for life-threatening alterations in electrolytes
3.Increased risk of asthma-related deaths when LTBAs are used
Digoxin levels need to be monitored closely when the following medication is started:
1.Loratadine
2.Diphenhydramine
3.Ipratropium
4.Albuterol
4.Albuterol
Christy has exercise-induced and mild persistent asthma and is prescribed two puffs of albuterol 15 minutes before exercise and as needed for wheezing. One puff per day of beclomethasone (QVAR) is also prescribed. Teaching regarding her inhalers includes:
1. Use one to two puffs of albuterol per day to prevent an attack with no more than eight puffs per day
2. Beclomethasone needs to be used every day to treat her asthma
3. Report any systemic side effects she is experiencing, such as weight gain
4. Use the albuterol metered-dose inhaler (MDI) immediately after her corticosteroid MDI to facilitate bronchodilation
- Beclomethasone needs to be used every day to treat her asthma
The bronchodilator of choice for patients taking propranolol is:
1.Albuterol
2.Pirbuterol
3.Formoterol
4.Ipratropium
4.Ipratropium
Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all?
1.Betamethasone, an inhaled corticosteroid
2.Salmeterol, an inhaled long-acting beta-agonist
3.Albuterol, a short-acting beta-agonist
4.Montelukast, a leukotriene modifier
2.Salmeterol, an inhaled long-acting beta-agonist
Tiotropium bromide (Spiriva) is an inhaled anticholinergic:
1. Used for the treatment of chronic obstructive pulmonary disease (COPD)
2. Used in the treatment of asthma
3. Combined with albuterol for treatment of asthma exacerbations
4. Combined with fluticasone for the treatment of persistent asthma
- Used for the treatment of chronic obstructive pulmonary disease (COPD)
Montelukast (Singulair) may be prescribed for:
1. A 6-year-old child with exercise-induced asthma
2. A 2-year-old child with moderate persistent asthma
3. An 18-month-old child with seasonal allergic rhinitis
4. None of the above; montelukast is not approved for use in children
- A 2-year-old child with moderate persistent asthma
When prescribing montelukast (Singulair) for asthma, patients or parents of patients should be instructed:
1. Montelukast twice a day is started when there is an asthma exacerbation.
2. Patients may experience weight gain on montelukast.
3. Aggression, anxiety, depression, and/or suicidal thoughts may occur when taking montelukast.
4. Lethargy and hypersomnia may occur when taking montelukast.
- Aggression, anxiety, depression, and/or suicidal thoughts may occur when taking montelukast.
The known drug interactions with the inhaled corticosteroid beclomethasone (QVAR) include:
1. Albuterol
2. MMR vaccine
3. Insulin
4. None of the above
- None of the above
When educating patients who are starting on inhaled corticosteroids, the provider should tell them that:
1. They need to get any live vaccines before starting the medication.
2. Inhaled corticosteroids need to be used daily during asthma exacerbations to be effective.
3. Patients should rinse their mouths out after using the inhaled corticosteroid to prevent thrush.
4. They can triple the dose number of inhalations of medication during colds to prevent needing systemic steroids.
- Patients should rinse their mouths out after using the inhaled corticosteroid to prevent thrush.
Howard is a 72-year-old male who occasionally takes diphenhydramine for his seasonal allergies. Monitoring for this patient taking diphenhydramine would include assessing for:
1. Urinary retention
2. Cardiac output
3. Peripheral edema
4. Skin rash
- Urinary retention
When recommending dimenhydrinate (Dramamine) to treat motion sickness, patients should be instructed to:
1. Take the dimenhydrinate after they get nauseated
2. Drink lots of water while taking the dimenhydrinate
3. Take the dimenhydrinate 15 minutes before it is needed
4. Double the dose if one tablet is not effective
- Take the dimenhydrinate 15 minutes before it is needed
Cough and cold medications that contain a sympathomimetic decongestant such as phenylephrine should be used cautiously in what population:
1. Older adults
2. Hypertensive patients
3. Infants
4. All of the above
- All of the above
Decongestants such as pseudoephedrine (Sudafed):
1. Are Schedule III drugs in all states
2. Should not be prescribed or recommended for children under 4 years of age
3. Are effective in treating the congestion children experience with the common cold
4. May cause drowsiness in patients of all ages
- Should not be prescribed or recommended for children under 4 years of age
Prior to developing a plan for the treatment of asthma, the patient’s asthma should be classified according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is classified as asthma symptoms that occur:
1.Daily
2.Daily and limit physical activity
3.Less than twice a week
4.More than twice a week and less than once a day
4.More than twice a week and less than once a day
Martin is a 60-year-old patient with hypertension. The first-line decongestant to prescribe would be:
1. Oral pseudoephedrine
2. Oral phenylephrine
3. Nasal oxymetazoline
4. Nasal azelastine
- Nasal oxymetazoline
In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms occur:
1.At nighttime one to two times a month
2.At nighttime three to four times a month
3.Less than twice a week
4.Daily
2.At nighttime three to four times a month
In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms occur:
1.At nighttime one to two times a month
2.At nighttime three to four times a month
3.Less than twice a week
4.Daily
2.At nighttime three to four times a month
A stepwise approach to the pharmacologic management of asthma:
1.Begins with determining the severity of asthma and assessing asthma control
2.Is used when asthma is severe and requires daily steroids
3.Allows for each provider to determine their personal approach to the care of asthmatic patients
4.Provides a framework for the management of severe asthmatics, but is not as helpful when patients have intermittent asthma
1.Begins with determining the severity of asthma and assessing asthma control
Treatment for mild intermittent asthma is:
1.Daily inhaled medium-dose corticosteroids
2.Short-acting beta-2-agonists (albuterol) as needed
3.Long-acting beta-2-agonists every morning as a preventative
4.Montelukast (Singulair) daily
2.Short-acting beta-2-agonists (albuterol) as needed
The first-line therapy for mild-persistent asthma is:
1.High-dose montelukast
2.Theophylline
3.Low-dose inhaled corticosteroids
4.Long-acting beta-2-agonists
3.Low-dose inhaled corticosteroids
Monitoring a patient with persistent asthma includes:
1.Monitoring how frequently the patient has an upper respiratory infection (URI) during treatment
2. Monthly in-office spirometry testing
3. Determining if the patient has increased use of his or her long-acting beta-2-agonist due to exacerbations
4. Evaluating the patient every 1 to 6 months to determine if the patient needs to step up or down in their therapy
- Evaluating the patient every 1 to 6 months to determine if the patient needs to step up or down in their therapy
Asthma exacerbations at home are managed by the patient by:
1. Increasing frequency of beta-2-agonists and contacting their provider
2. Doubling inhaled corticosteroid doses
3. Increasing frequency of beta-2-agonists
4. Starting montelukast (Singulair)
- Increasing frequency of beta-2-agonists and contacting their provider
Patients who are at risk of a fatal asthma attack include patients:
1. With moderate persistent asthma
2. With a history of requiring intubation or ICU admission for asthma
3. Who are on daily inhaled corticosteroid therapy
4. Who are pregnant
- With a history of requiring intubation or ICU admission for asthma
Pregnant patients with asthma may safely use _______throughout their pregnancy.
1. Oral terbutaline
2. Prednisone
3. Inhaled corticosteroids (budesonide)
4. Montelukast (Singulair)
- Inhaled corticosteroids (budesonide)
Medications used in the management of patients with chronic obstructive pulmonary disease (COPD) include:
1. Inhaled beta-2-agonists
2. Inhaled anticholinergics (ipratropium)
3. Inhaled corticosteroids
4. All of the above
- All of the above
Education for patients who use an inhaled beta-agonist and an inhaled corticosteroid includes:
1. Use the inhaled corticosteroid first, followed by the inhaled beta-agonists.
2. Use the inhaled beta-agonist first, followed by the inhaled corticosteroid.
3. Increase fluid intake to 3 liters per day.
4. Avoid use of aspirin or ibuprofen while using inhaled medications
- Use the inhaled beta-agonist first, followed by the inhaled corticosteroid.
The first-line drug choice for a previously healthy adult patient diagnosed with community-acquired pneumonia would be:
1.Ciprofloxacin
2.Azithromycin
3.Amoxicillin
4.Doxycyclin
2.Azithromycin
??
The first-line antibiotic choice for a patient with comorbidities or who is immunosuppressed who has pneumonia and can be treated as an outpatient would be:
1.Levofloxacin
2.Amoxicillin
3.Ciprofloxacin
4.Cephalexin
1.Levofloxacin
??
The most common bacterial pathogen in community-acquired pneumonia is:
1.Haemophilus influenzae
2.Staphylococcus aureus
3.Mycoplasma pneumoniae
4.Streptococcus pneumoniae
4.Streptococcus pneumoniae
If an adult patient with comorbidities cannot reliably take oral antibiotics to treat pneumonia, an appropriate initial treatment option would be:
1.IV or IM gentamicin
2.IV or IM ceftriaxone
3.IV amoxicillin
4.IV ciprofloxacin
2.IV or IM ceftriaxone
Samantha is 34 weeks pregnant and has been diagnosed with pneumonia. She is stable enough to be treated as an outpatient. What would be an appropriate antibiotic to prescribe?
1.Levofloxacin
2.Azithromycin
3.Amoxicillin
4.Doxycycline
2.Azithromycin
Adults with pneumonia who are responding to antimicrobial therapy should show improvement in their clinical status in:
1.12 to 24 hours
2.24 to 36 hours
3.48 to 72 hours
4.4 or 5 days
3.48 to 72 hours